Display options
Cite
Li X, Zhang C, Zhou QY. Overexpression of Prokineticin 2 in Transgenic Mice Leads to Reduced Circadian Behavioral Rhythmicity and Altered Molecular Rhythms in the Suprachiasmatic Clock. J Circadian Rhythms. 2018;16:13doi: 10.5334/jcr.170.
Li, X., Zhang, C., & Zhou, Q. Y. (2018). Overexpression of Prokineticin 2 in Transgenic Mice Leads to Reduced Circadian Behavioral Rhythmicity and Altered Molecular Rhythms in the Suprachiasmatic Clock. Journal of circadian rhythms, 1613. https://doi.org/10.5334/jcr.170
Li, Xiaohan, et al. "Overexpression of Prokineticin 2 in Transgenic Mice Leads to Reduced Circadian Behavioral Rhythmicity and Altered Molecular Rhythms in the Suprachiasmatic Clock." Journal of circadian rhythms vol. 16 (2018): 13. doi: https://doi.org/10.5334/jcr.170
Li X, Zhang C, Zhou QY. Overexpression of Prokineticin 2 in Transgenic Mice Leads to Reduced Circadian Behavioral Rhythmicity and Altered Molecular Rhythms in the Suprachiasmatic Clock. J Circadian Rhythms. 2018 Nov 06;16:13. doi: 10.5334/jcr.170. PMID: 30473715; PMCID: PMC6234414.
Copy Download .nbib Format: NLM
Share it on

J Circadian Rhythms. 2018 Nov 06;16:13. doi: 10.5334/jcr.170.

Overexpression of Prokineticin 2 in Transgenic Mice Leads to Reduced Circadian Behavioral Rhythmicity and Altered Molecular Rhythms in the Suprachiasmatic Clock.

Journal of circadian rhythms

Xiaohan Li, Chengkang Zhang, Qun-Yong Zhou

Affiliations

  1. Department of Pharmacology, University of California, Irvine, CA 92697, US.

PMID: 30473715 PMCID: PMC6234414 DOI: 10.5334/jcr.170

Abstract

In mammals, the master pacemaker driving circadian rhythms is thought to reside in the suprachiasmatic nuclei (SCN) of the anterior hypothalamus. A clear view of molecular clock mechanisms within the SCN neurons has been elucidated. In contrast, much less is known about the output mechanism by which the SCN circadian pacemaker sends timing information for eventual control of physiological and behavioral rhythms. Two secreted molecules, prokineticin 2 (PK2) and vasopressin, that are encoded by respective clock-controlled genes, have been indicated as candidate SCN output molecules. Several lines of evidence have emerged that support the role of PK2 as an output signal for the SCN circadian clock, including the reduced circadian rhythms in mice that are deficient in PK2 or its receptor, PKR2. In the current study, transgenic mice with the overexpression of PK2 have been generated. These transgenic mice displayed reduced oscillation of the PK2 expression in the SCN and decreased amplitude of circadian locomotor rhythm, supporting the important signaling role of PK2 in the regulation of circadian rhythms. Altered molecular rhythms were also observed in the SCN in the transgenic mice, indicating that PK2 signaling also regulates the operation of core clockwork. This conclusion is consistent with recent reports showing the likely signaling role of PK2 from the intrinsically photosensitive retinal ganglion cells to SCN neurons. Thus, PK2 signaling plays roles in both the input and the output pathways of the SCN circadian clock.

Keywords: circadian clock; intrinsically photosensitive retinal ganglion cells; output; overexpression; prokineticin 2; suprachiasmatic; transgenic mice

References

  1. Nature. 1983 Jul 14-20;304(5922):163-4 - PubMed
  2. Mol Brain. 2016 Aug 18;9(1):78 - PubMed
  3. Sleep. 2007 Mar;30(3):247-56 - PubMed
  4. J Biol Rhythms. 2006 Dec;21(6):458-69 - PubMed
  5. Cell. 1999 Jan 8;96(1):57-68 - PubMed
  6. Nature. 2002 Aug 29;418(6901):935-41 - PubMed
  7. PLoS One. 2011;6(6):e20263 - PubMed
  8. J Comp Neurol. 1987 Apr 8;258(2):204-29 - PubMed
  9. BMC Neurosci. 2005 Mar 11;6:17 - PubMed
  10. J Circadian Rhythms. 2015 Apr 01;13:2 - PubMed
  11. Nature. 2002 May 23;417(6887):405-10 - PubMed
  12. J Neuroendocrinol. 2014 Jan;26(1):2-10 - PubMed
  13. J Comp Neurol. 2001 May 7;433(3):312-34 - PubMed
  14. Nature. 1996 Aug 29;382(6594):810-3 - PubMed
  15. J Neurosci. 2006 Nov 8;26(45):11615-23 - PubMed
  16. Prog Brain Res. 2012;199:119-27 - PubMed
  17. Eur J Neurosci. 2007 Jan;25(2):425-34 - PubMed
  18. J Comp Neurol. 2005 Dec 5;493(1):92-8 - PubMed
  19. Science. 2000 Apr 28;288(5466):682-5 - PubMed
  20. J Biol Rhythms. 2006 Dec;21(6):470-81 - PubMed
  21. J Neurosci. 1996 Sep 1;16(17):5555-65 - PubMed
  22. Peptides. 2000 Jun;21(6):811-6 - PubMed
  23. Neuron. 2015 Mar 4;85(5):895-8 - PubMed
  24. J Comp Neurol. 1987 Apr 8;258(2):230-52 - PubMed
  25. Cell. 2002 May 3;109(3):307-20 - PubMed
  26. Neuron. 2015 Mar 4;85(5):1103-16 - PubMed
  27. Science. 2013 Oct 4;342(6154):85-90 - PubMed
  28. Nature. 2002 Aug 1;418(6897):534-9 - PubMed
  29. Brain Res Brain Res Rev. 2005 Nov;49(3):429-54 - PubMed
  30. J Comp Neurol. 2006 Oct 20;498(6):796-809 - PubMed
  31. PLoS One. 2009 Sep 28;4(9):e7151 - PubMed
  32. Nat Rev Neurosci. 2011 Sep 02;12(10):553-69 - PubMed
  33. J Biol Chem. 2002 May 31;277(22):19276-80 - PubMed
  34. Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):648-53 - PubMed
  35. Prog Brain Res. 1998;119:351-64 - PubMed
  36. Prog Brain Res. 1996;111:229-40 - PubMed
  37. Annu Rev Physiol. 2010;72:551-77 - PubMed
  38. Am J Physiol Regul Integr Comp Physiol. 2009 Mar;296(3):R824-30 - PubMed
  39. Prog Neurobiol. 2007 Aug;82(5):229-55 - PubMed

Publication Types

Grant support